^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    threitolceramide 6 liposomal (PORT-2)

    i
    Other names: PORT-2, IMM60 liposomal, ThrCer6
    Associations
    News
    Trials
    Company:
    AlphaTON Capital
    Drug class:
    iNKT agonist
    Related drugs:
    Associations
    News
    Trials